| abstract |
A phytocomposition is described comprising: (a) from 0.01% to 26% by weight of Arnica montana extract; (b) from 0.01% to 26% by weight of Rosmarinus officinalis extract; (c) from 0.01% to 26% by weight of Zingiber officinale extract; and, (d) from 0.01% to 26% by weight of Boswellla serrata extract. This phytocomposition can be used in combination with a pharmaceutically acceptable carrier to obtain a pharmaceutical composition useful in the treatment of muscular, arthritic and rheumatic pain in a patient, which are caused by joint diseases, particularly rheumatoid arthritis, osteoarthritis, fibromyalgia, gouty arthritis. , psoriatic arthritis, lupus and juvenile arthritis. |